Monster Beverage
MNST
$42.94
+1.90%
Monster Beverage Corporation is a global leader in the energy drink category within the nonalcoholic ready-to-drink beverage market, with a portfolio spanning Monster Energy, Monster Ultra, Java Monster, Juice Monster, Reign, NOS, Bang, and Mother, plus a small alcohol segment following its 2022 craft brewer acquisition; roughly two-thirds of revenue is generated in the US and Canada. The company operates an asset-light model, controlling branding and innovation while outsourcing manufacturing to co-packers and distribution to bottlers within the Coca-Cola system under a 20-year agreement, with Coca-Cola holding a 20% stake. The current investor narrative centers on exceptional international momentum — international sales reportedly surging 34.6% and now representing 46% of revenue — which is driving a debate over whether a mature-category leader can sustain hyper-growth-like expansion. This growth enthusiasm is tempered by valuation anxiety, with the stock carrying a premium multiple and headlines questioning whether investors are already pricing in too much success, while a 2-for-1 stock split completed in August 2026 has broadened retail accessibility and attention.…
MNST
Monster Beverage
$42.94
Related headlines
Investment Opinion: Should I buy MNST Today?
The synthesized recommendation is Hold, with a bias toward accumulating on weakness. The core thesis is that Monster Beverage is a high-quality compounder with exceptional international growth and a fortress balance sheet, but its premium valuation and recent momentum breakdown warrant caution. The analyst consensus rating of 'buy' (mean 2.04) and average target price of $50.24 imply approximately +16.5% upside, suggesting the stock is not overvalued enough to warrant a Sell, but the risk/reward is balanced.
Supporting evidence includes: 1) Revenue growth of 26.89% year over year in Q1 2026, driven by 34.6% international growth; 2) Net margin of 24.2% and operating margin of 31.02%, well above typical staples peers; 3) Zero debt-to-equity and a 3.70 current ratio, providing financial stability; 4) TTM free cash flow of $2.072 billion, demonstrating strong cash generation. However, the trailing PE of 39.32x and forward PE of 32.93x represent a 40%–60% premium to the sector, and the PEG ratio of 1.31 suggests the premium is only partially supported by growth. The stock's recent 9.83% one-month decline and negative relative strength indicate waning momentum.
The biggest risks that could invalidate the thesis are: 1) A deceleration in international growth below 20%, which would likely trigger multiple compression; 2) Increased competitive pressure from Celsius or other brands eroding market share; 3) A US market slowdown impacting the core business. The rating would upgrade to Buy if the stock pulls back to the mid-$30s (approaching the analyst low target of $35.00) or if international growth accelerates above 40%. It would downgrade to Sell if revenue growth falls below 15% or if gross margins drop below 50%. Relative to its history, the stock is fairly valued to slightly overvalued; the PE of 39.32x is in the middle-to-upper portion of its historical 30x–47x range, but the premium is justified only if growth remains robust.
Sign up to view all
MNST 12-Month Price Forecast
Monster Beverage presents a balanced risk/reward profile. The company's exceptional international growth and fortress balance sheet are undeniable strengths, but the premium valuation and recent negative momentum suggest the stock is fairly valued in the near term. The wide analyst target range reflects uncertainty about the sustainability of growth. I would upgrade to bullish if the stock pulls back to the mid-$30s or if international growth accelerates above 35% for multiple quarters. I would downgrade to bearish if revenue growth decelerates below 15% or if gross margins fall below 50%. The base case of $48–$52 appears most likely, implying modest upside from current levels.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Monster Beverage's 12-month outlook, with a consensus price target around $50.24 and implied upside of +17.0% versus the current price.
Average Target
$50.24
0 analysts
Implied Upside
+17.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$35 - $57
Analyst target range
Coverage is robust, with 23 analysts following Monster and a consensus recommendation of "buy" (recommendation mean of 2.04 on a scale where lower is more bullish). The average price target is $50.24, which against the current price of $43.11 implies approximately +16.5% upside, indicating a moderately bullish consensus that nonetheless reflects tempered expectations after the recent pullback. Consensus revenue estimates of $13.53 billion and EPS estimates of $1.77 for the coming year underpin the constructive stance, and the recent institutional ratings flow is stable-to-positive, with Citigroup reiterating Buy in July 2026, Wells Fargo and Morgan Stanley maintaining Overweight, and Rothschild & Co upgrading to Buy from Neutral in May 2026, though JP Morgan and UBS remain Neutral. The target range spans a low of $35.00 to a high of $57.00, a wide $22 spread that signals meaningful disagreement about the growth trajectory; the high target of $57.00 implies roughly +32% upside and likely assumes sustained international acceleration, margin expansion, and multiple maintenance, while the low target of $35.00 implies about -19% downside and prices in growth deceleration, competitive pressure from rivals like Celsius, or multiple compression. The wide spread, combined with the recent 1-month underperformance of -9.83% and negative relative strength, suggests the market is in a wait-and-see mode pending evidence that the international growth story can offset any US slowdown; the absence of recent downgrades is a modest positive signal, but the Neutral ratings from JP Morgan and UBS indicate that not all analysts are convinced the premium valuation is warranted.
Bulls vs Bears: MNST Investment Factors
The bull case for Monster Beverage rests on exceptional international momentum, a fortress balance sheet, and robust profitability that collectively justify a premium valuation. However, the bear case is gaining traction: the stock has fallen nearly 10% over the past month, underperforming the market significantly, and the premium PE of 39.32x leaves little margin for error if growth decelerates. The most important tension in the investment debate is whether Monster's international growth can sustain its current trajectory to justify the premium multiple, or whether competitive pressures and a US slowdown will force a re-rating. Currently, the bear side has stronger near-term evidence due to the momentum breakdown and valuation anxiety, but the long-term bull case remains intact if international expansion continues. The single most critical factor is the durability of the 34.6% international growth rate; any sign of deceleration would likely trigger a sharp multiple compression.
Bullish
- International growth accelerating at 34.6%: International sales are reportedly surging 34.6% and now represent 46% of revenue, up from a historically US-centric base. This is the primary driver behind Q1 2026 revenue growth of 26.89% year over year to $2.353 billion, demonstrating that Monster can sustain hyper-growth-like expansion even as a mature category leader.
- Fortress balance sheet with zero debt: Debt-to-equity is 0, the current ratio is 3.70, and cash at the end of Q1 2026 was $2.040 billion. This provides immense financial flexibility to fund growth internally, repurchase shares ($134.0 million in Q1 2026), and withstand economic downturns without solvency risk.
- Exceptional profitability and cash generation: Q1 2026 net margin was 24.2%, gross margin 54.96%, and operating margin 31.02%, with EBITDA margin at 33.1%. TTM free cash flow of $2.072 billion on just $20.6 million of quarterly capex underscores the asset-light model's cash-generative power.
- Analyst consensus sees 16.5% upside: With 23 analysts covering the stock, the consensus recommendation is 'buy' (mean 2.04) and the average price target of $50.24 implies approximately +16.5% upside from the current $43.11. Recent institutional actions include Citigroup reiterating Buy, Wells Fargo and Morgan Stanley maintaining Overweight, and Rothschild & Co upgrading to Buy.
Bearish
- Premium valuation leaves little room for error: The trailing PE of 39.32x and forward PE of 32.93x represent a substantial premium to large-cap staples peers that typically trade in the low-to-mid 20s on forward earnings. The PS ratio of 9.02x and EV/EBITDA of 27.94x further indicate the market is pricing in continued strong execution, making the stock vulnerable to any growth disappointment.
- Recent momentum breakdown and underperformance: The stock is down 9.83% over the past month and 10.54% over three months, significantly underperforming the S&P 500 by 10.52% and 16.35% respectively over those periods. This sharp negative divergence from the +33.49% one-year gain suggests profit-taking or a valuation-driven pullback that could persist.
- Wide analyst target range signals disagreement: The target range spans a low of $35.00 to a high of $57.00, a $22 spread that reflects meaningful disagreement about the growth trajectory. The low target implies roughly -19% downside, pricing in growth deceleration or competitive pressure, while JP Morgan and UBS remain Neutral, indicating not all analysts are convinced the premium is warranted.
- Competitive threats from Celsius and others: Celsius's Q2 miss and declining flagship sales signal growth troubles for a key competitor, but Celsius still offers higher growth potential and could pressure Monster's market share. The energy drink category is becoming increasingly crowded, and Monster's premium valuation assumes it can maintain leadership without significant share loss.
MNST Technical Analysis
Monster Beverage is in a broad recovery uptrend, with the shares up 33.49% over the past year, though the current price of $43.11 sits at roughly 60.6% of the 52-week range between a low of $32.21 and a high of $50.17. That mid-to-upper range positioning signals the stock has recovered substantially from its lows but has not reclaimed its highs, leaving room for either continuation toward resistance or a stall if momentum fades. The 17.7% maximum drawdown underscores that this recovery has not been linear, and the stock remains meaningfully below its peak. Recent momentum has turned sharply negative and is diverging from the longer-term trend: the 1-month change of -9.83% and 3-month change of -10.54% contrast starkly with the +33.49% 1-year gain, while the 6-month change of +20.03% shows the weakness is concentrated in the last quarter. Relative strength versus SPY is -10.52% over 1 month and -16.35% over 3 months, confirming significant underperformance, even as the 1-year relative strength remains positive at +16.27%; this pattern suggests a momentum breakdown within an intact longer-term uptrend, consistent with profit-taking or a valuation-driven pullback rather than a full trend reversal. Key technical levels are defined by the 52-week low at $32.21 as major support and the 52-week high at $50.17 as resistance; a breakout above $50.17 would signal renewed leadership and likely require a fundamental catalyst, while a breakdown below $32.21 would invalidate the recovery thesis and point to deeper deterioration. With a beta of just 0.515, Monster is roughly half as volatile as the broader market, which cushions drawdowns but also means rallies may be more muted; the short ratio of 4.35 indicates a modest short base that is not a dominant driver of price action.
Beta
0.52
0.52x market volatility
Max Drawdown
-17.7%
Largest decline past year
52-Week Range
$33-$50
Price range past year
Annual Return
+27.1%
Cumulative gain past year
| Period | MNST Return | S&P 500 |
|---|---|---|
| 1m | -3.3% | +0.6% |
| 3m | -12.0% | +3.3% |
| 6m | +18.7% | +17.4% |
| 1y | +27.1% | +15.0% |
| ytd | +12.8% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MNST Fundamental Analysis
Monster's revenue trajectory is accelerating impressively for a mature consumer staples name: Q1 2026 revenue reached $2.353 billion, up 26.89% year over year, following Q4 2025 revenue of $2.131 billion and Q3 2025 revenue of $2.197 billion, with the year-ago Q1 2025 base at $1.855 billion. The sequential and year-over-year progression shows growth re-accelerating through 2025 into 2026, and segment data confirms the energy drinks business is the engine at $2.189 billion, dwarfing alcohol brands at $32.7 million and strategic brands at $126.7 million. With international sales reportedly growing 34.6% and now 46% of revenue, the growth story is increasingly global, which supports a higher-quality, longer-duration growth case than a US-only narrative would. Profitability is robust and improving: Q1 2026 net income was $569.5 million on a 24.2% net margin, with gross margin at 54.96% and operating margin at 31.02%, while EBITDA of $779.1 million represented a 33.1% EBITDA margin. Gross margin has been relatively stable in the 54.9%–55.7% band over recent quarters, and the Q1 2026 net margin of 24.2% compares favorably to the 21.1% in Q4 2025 and 23.9% in Q3 2025, indicating margin expansion alongside growth. The balance sheet is exceptionally strong: debt-to-equity is 0, the current ratio is 3.70, and ROE stands at 23.08% with ROA at 17.48%, reflecting a highly capital-efficient, asset-light model. Free cash flow is substantial, with TTM FCF of $2.072 billion and Q1 2026 FCF of $584.4 million on operating cash flow of $605.0 million against just $20.6 million of capital expenditure, meaning the company funds growth internally with ease; cash at the end of Q1 2026 was $2.040 billion, and the company repurchased $134.0 million of stock in the quarter, returning capital while maintaining a fortress balance sheet.
Quarterly Revenue
$2.5B
2026-06
Revenue YoY Growth
+20.2%
YoY Comparison
Gross Margin
56.0%
Latest Quarter
Free Cash Flow
$2.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MNST Overvalued?
Because Monster is solidly profitable — Q1 2026 net income of $569.5 million and positive EPS — the PE ratio is the appropriate primary metric, and the stock trades at a trailing PE of 39.32x versus a forward PE of 32.93x. The gap between trailing and forward multiples implies the market expects meaningful earnings growth, consistent with consensus EPS estimates of $1.77 for the coming year versus the trailing figure, and the PEG ratio of 1.31 suggests the premium is at least partially supported by expected growth. On other metrics, the stock carries a PS ratio of 9.02x, a PB ratio of 9.07x, an EV/EBITDA of 27.94x, and an EV/Sales of 8.71x, all of which point to a premium-priced compounder. Relative to the broader nonalcoholic beverage sector, Monster's trailing PE of 39.32x and forward PE of 32.93x represent a substantial premium — the sector's large-cap staples peers typically trade in the low-to-mid 20s on forward earnings — implying a premium of roughly 40%–60% depending on the peer set. That premium is arguably justified by Monster's 26.89% revenue growth, 23.08% ROE, 55.85% gross margin, and 29.17% operating margin, which are well above typical staples-company levels, though it leaves little margin for error if growth decelerates. Historically, Monster's PE has ranged from roughly 30x to 47x over the past several years, with the current 39.32x sitting in the middle-to-upper portion of that band; the PS ratio of 9.02x is well below the 28x–35x levels seen in 2022–2023 on a pre-split basis but the comparison is distorted by the stock split and share count changes, so the PE is the cleaner historical anchor. The current multiple suggests the market is pricing in continued strong execution but is not at the euphoric extreme seen in prior peak periods, leaving the stock sensitive to any growth disappointment.
PE
39.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 30x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.9x
Enterprise Value Multiple
Investment Risk Disclosure
Monster's financial risks are relatively contained given its zero debt-to-equity ratio, 3.70 current ratio, and $2.040 billion in cash, but the company's premium valuation introduces earnings volatility risk. The trailing PE of 39.32x and forward PE of 32.93x mean that any earnings miss could lead to outsized stock price declines, as the market has priced in high expectations. Additionally, while gross margin has been stable in the 54.9%–55.7% band, input cost inflation or promotional spending could pressure margins, especially as the company invests to sustain international growth. Revenue concentration in the US and Canada (roughly two-thirds) remains a risk if regional demand softens.
Market and competitive risks are significant. The stock's beta of 0.515 suggests lower volatility than the market, but its premium valuation makes it vulnerable to sector rotation and multiple compression if growth stocks fall out of favor. Competition from Celsius and other energy drink brands is intensifying; Celsius's recent Q2 miss and declining flagship sales highlight the category's challenges, but Celsius still offers higher growth potential and could erode Monster's market share. Regulatory headwinds, such as potential labeling requirements or taxes on energy drinks, could also impact demand. Recent news headlines questioning whether investors are 'pricing in too much success' reflect growing skepticism about the premium multiple.
The worst-case scenario would involve a combination of decelerating international growth, US market share loss, and multiple compression. If international growth slows to single digits and the forward PE compresses to the low 20s (in line with staples peers), the stock could fall toward the analyst low target of $35.00, representing approximately -19% downside from the current $43.11. A more severe scenario, such as a broader market downturn or a significant competitive disruption, could push the stock toward its 52-week low of $32.21, implying a -25% decline. Given the 17.7% maximum drawdown over the past year, investors should be prepared for further volatility if growth disappoints.
FAQ
The key risks for MNST include: 1) Valuation risk: the premium PE of 39.32x makes the stock vulnerable to multiple compression if growth disappoints; 2) Competitive risk: Celsius and other brands are intensifying competition in the energy drink category, potentially eroding market share; 3) Concentration risk: roughly two-thirds of revenue comes from the US and Canada, so a regional slowdown could disproportionately impact results; 4) Macro risk: a broader market downturn or sector rotation out of consumer staples could pressure the stock, despite its low beta of 0.515. The most severe risk is a sharp deceleration in international growth, which could push the stock toward the analyst low target of $35.00 (-19% downside) or the 52-week low of $32.21 (-25% downside).
The 12-month forecast for MNST includes three scenarios: Bull case (25% probability) targets $55–$57, assuming international growth exceeds 35% and margins expand; Base case (55% probability) targets $48–$52, assuming growth moderates to 25%–30% and the stock trades toward the analyst average target of $50.24; Bear case (20% probability) targets $32.21–$35.00, assuming international growth falls below 15% and multiple compression occurs. The base case is most likely, implying approximately 11%–21% upside from the current $43.11. The key assumption behind the base case is that international growth remains robust but moderates, and the premium valuation is sustained by earnings growth.
MNST appears fairly valued to slightly overvalued relative to its peers and history. The trailing PE of 39.32x and forward PE of 32.93x represent a 40%–60% premium to large-cap staples peers, which typically trade in the low-to-mid 20s on forward earnings. The PEG ratio of 1.31 suggests the premium is partially justified by expected growth, but not entirely. Historically, the stock's PE has ranged from 30x to 47x, placing the current multiple in the middle-to-upper portion of that band. The PS ratio of 9.02x and EV/EBITDA of 27.94x also indicate a premium. The market is pricing in continued strong execution, leaving little room for error. If growth decelerates, the multiple could compress significantly, making the stock overvalued at current levels.
MNST is a good buy for long-term investors seeking exposure to a high-quality growth compounder, but the current risk/reward is balanced. The stock trades at a premium valuation (forward PE of 32.93x) and has recently underperformed the market, down 9.83% over the past month. Analyst consensus sees 16.5% upside to the average target of $50.24, but the wide target range ($35–$57) reflects uncertainty. The biggest downside risk is multiple compression if international growth decelerates. For investors with a long time horizon and tolerance for volatility, accumulating on dips toward the mid-$30s could be attractive. However, at $43.11, the stock is fairly valued and may be better suited for a Hold until growth visibility improves.
MNST is better suited for long-term investment (minimum 3–5 years) rather than short-term trading. The company's growth story is driven by international expansion, which will play out over multiple years, and its low beta of 0.515 means it is less likely to deliver quick trading gains. The stock does not pay a dividend (payout ratio 0), so returns depend entirely on capital appreciation. Earnings visibility is moderate, with analyst estimates for EPS of $1.77 in the coming year, but the wide target range suggests uncertainty. Short-term traders may find opportunities around earnings reports or news events, but the recent momentum breakdown (-9.83% 1-month) indicates near-term headwinds. A long-term holding period allows investors to benefit from the company's international growth and strong cash flow generation.